CXCL12/CXCR4 Delivers Pro-Apoptotic Activity in FLT3/ITD+ Cells by Antagonizing Expression of Genes Deregulated by FLT3/ITD

被引：0
|
作者：
Fukuda, Seiji [1 ]
Hirade, Tomohiro [1 ]
Onishi, Chie [2 ]
Taketani, Takeshi [1 ]
机构：
[1] Shimane Univ, Dept Pediat, Matsue, Shimane, Japan
[2] Shimane Univ, Sch Med, Dept Oncol & Hematol, Matsue, Shimane, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OS27-3-4
引用
收藏
页码：S84 / S84
页数：1
相关论文
共 50 条
  • [1] Cxcr4low FLT3/ITD+ Cells Exhibit Enhanced Resistance to the FLT3 Inhibitor Quizartinib Compared to Cxcr4high FLT3/ITD+ Cells By Elevating Runx1 Expression
    Fukuda, Seiji
    Onishi, Chie
    Taketani, Takeshi
    BLOOD, 2019, 134
  • [2] DISRUPTING CDKN1A SECONDARY TO FLT3/ITD INHIBITION IS RESPONSIBLE FOR RESISTANCE TO FLT3/ITD INHIBITOR AC220 IN FLT3/ITD+ CELLS
    Fukuda, Seiji
    Abe, Mariko
    Hirade, Tomohiro
    Yamaguchi, Seiji
    EXPERIMENTAL HEMATOLOGY, 2015, 43 (09) : S63 - S63
  • [3] The magnitude of CXCR4 signaling regulates resistance to quizartinib in FLT3/ITD+ cells via RUNX1
    Fukuda, Seiji
    Matsuda, Nozomi
    Shoji, Tsukimi
    Onishi, Chie
    Hirade, Tomohiro
    Taketani, Takeshi
    Pelus, Louis M.
    LEUKEMIA RESEARCH, 2023, 124
  • [4] CAR T-cells targeting FLT3 have potent activity against FLT3−ITD+ AML and act synergistically with the FLT3-inhibitor crenolanib
    Hardikkumar Jetani
    Irene Garcia-Cadenas
    Thomas Nerreter
    Simone Thomas
    Julian Rydzek
    Javier Briones Meijide
    Halvard Bonig
    Wolfgang Herr
    Jordi Sierra
    Hermann Einsele
    Michael Hudecek
    Leukemia, 2018, 32 : 1168 - 1179
  • [5] FLT3 Inhibitor Treatment Increases FLT3 Expression That Exposes FLT3-ITD+ AML Blasts to Elimination By FLT3 CAR-T Cells
    Jetani, Hardikkumar
    Garcia-Cadenas, Irene
    Nerreter, Thomas
    Goetz, Ralph
    Sierra, Jorge
    Bonig, Halvard
    Sauer, Markus
    Einsele, Hermann
    Hudecek, Michael
    BLOOD, 2018, 132
  • [6] All-trans retinoic acid synergizes with FLT3 inhibition to eliminate FLT3/ITD+ leukemia stem cells in vitro and in vivo
    Ma, Hayley S.
    Greenblatt, Sarah M.
    Shirley, Courtney M.
    Duffield, Amy S.
    Bruner, J. Kyle
    Li, Li
    Bao Nguyen
    Jung, Eric
    Aplan, Peter D.
    Ghiaur, Gabriel
    Jones, Richard J.
    Small, Donald
    BLOOD, 2016, 127 (23) : 2867 - 2878
  • [7] Gilteritinib and Venetoclax Synergize to Eliminate FLT3/ITD+ Leukemia Cells through BIM
    Zhu, Ruiqi
    Li, Li
    Nguyen, Bao
    Duffield, Amy S.
    Small, Donald
    BLOOD, 2019, 134
  • [8] The Flt3 ligand/Flt3 axis regulates migration of normal and transformed hematopoietic cells by modulating SDF1α (CXCL12)/CXCR4 signaling.
    Fukuda, S
    Broxmeyer, HE
    Pelus, LM
    BLOOD, 2003, 102 (11) : 350A - 350A
  • [9] Inhibition of NOTCH4 sensitizes FLT3/ITD acute myeloid leukemia cells to FLT3 tyrosine kinase inhibition
    Zhu, Ruiqi
    Shirley, Courtney M.
    Chu, S. Haihua
    Li, Li
    Nguyen, Bao H.
    Seo, Jaesung
    Wu, Min
    Seale, Tessa
    Duffield, Amy S.
    Staudt, Louis M.
    Levis, Mark
    Hu, Yu
    Small, Donald
    LEUKEMIA, 2024, 38 (07) : 1581 - 1591
  • [10] Inhibition of NOTCH4 Sensitizes FLT3/ITD Acute Myeloid Leukemia Cells to FLT3 Tyrosine Kinase Inhibition
    Zhu, Ruiqi
    Shirley, Courtney
    Chu, Haihua
    Li, Li
    Bao Nguyen
    Seo, Jaesung
    Seale, Tessa
    Duffield, Amy
    Staudt, Louis M.
    Levis, Mark J.
    Hu, Yu
    Small, Donald
    BLOOD, 2023, 142
12345